A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

MorphoSys AG's subsidiary Constellation Pharmaceuticals partners with Novartis to research & commercialize pre-clinical of novel cancer target; MorphoSys receives US$23.0M payment, is eligible for milestone payments, royalties on net sales

INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "USE OF 1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS"

INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "METHODS FOR THE TREATMENT OF OSTEOARTHRITIS"

INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "TRIAZOLO-PYRIMIDINE ANALOGUES FOR TREATING DISEASES CONNECTED TO THE INHIBITON OF WERNER SYNDROME RECQ HELICASE (WRN)"

Novartis sells its Spanish headquarters in Barcelona, Spain, to the Freo Group as it reduces space for teleworking; Novartis to rent half of the 12,000 square-meter, nine floor building

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count